Proteomics International Laboratories Ltd

ASX:PIQ Stock Report

Market Cap: AU$89.1m

Proteomics International Laboratories Valuation

Is PIQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PIQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate PIQ's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate PIQ's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for PIQ?

Key metric: As PIQ is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PIQ. This is calculated by dividing PIQ's market cap by their current revenue.
What is PIQ's PS Ratio?
PS Ratio26.8x
SalesAU$3.28m
Market CapAU$89.08m

Price to Sales Ratio vs Peers

How does PIQ's PS Ratio compare to its peers?

The above table shows the PS ratio for PIQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average9x
CTE Cryosite
3.3xn/aAU$43.0m
OSL OncoSil Medical
20.1xn/aAU$31.4m
TRJ Trajan Group Holdings
1x6.0%AU$155.3m
GSS Genetic Signatures
11.8x41.9%AU$158.8m
PIQ Proteomics International Laboratories
26.8x40.2%AU$89.1m

Price-To-Sales vs Peers: PIQ is expensive based on its Price-To-Sales Ratio (26.8x) compared to the peer average (9x).


Price to Sales Ratio vs Industry

How does PIQ's PS Ratio compare vs other companies in the Global Life Sciences Industry?

25 CompaniesPrice / SalesEstimated GrowthMarket Cap
PIQ 26.8xIndustry Avg. 4.0xNo. of Companies31PS03.26.49.612.816+
25 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: PIQ is expensive based on its Price-To-Sales Ratio (26.8x) compared to the Global Life Sciences industry average (4x).


Price to Sales Ratio vs Fair Ratio

What is PIQ's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PIQ PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio26.8x
Fair PS Ratio6.3x

Price-To-Sales vs Fair Ratio: PIQ is expensive based on its Price-To-Sales Ratio (26.8x) compared to the estimated Fair Price-To-Sales Ratio (6.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies